ARKG250110C25000
- 0.05
- -0.46-90.20%
ARK Genomic Revolution ETF Newsroom
Recursion Pharmaceuticals Analyst Ratings
Cathie Wood Sells 36K Shares of Her Own Bitcoin Backed ARKB to Start off 2025
Beam Upgraded by Bernstein Ahead of AATD Data
Recursion Pharmaceuticals Announces 2 Key Investigational Oncology Drugs Advancing To Clinical Trials, Targeting High Unmet Needs In Hematologic Malignancies, Small-Cell Lung Cancer, & More
The "magic of the profit-making effect" is frequently appearing! NVIDIA's latest investment blueprint has been released, and these 13 companies are expected to take off.
Apart from NVIDIA itself, the key tracks and companies it invests in and pays attention to are also frequently favored by the U.S. stock market. The market believes that NVIDIA's investments often represent the development direction of the Industry, reflect the key areas of AI technology applications, and hint at potential technological breakthroughs.
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
Natera Shares Are Trading Higher After Canaccord Genuity Raised Its Price Target on the Stock From $165 to $180.
Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
Mizuho CEO Sees Global Boom in M&A After Trump Takes Office
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Adaptive Biotechnologies Analyst Ratings
Tempus Signs Agreements For In-Network Provider Status With Blue Cross Blue Shield Of Illinois, Blue Shield Of California And Avalon Healthcare Solutions
New Strategy? Cathie Wood's ARK Purchases Shares in Futu, Significantly Increased Its Stake in AI Healthcare Company Tempus AI and Sold Off Shopify
Cathie Wood's ARK ETF announced the daily Trade details for Tuesday, December 17, 2024.
Tempus AI Announced CMS Decision That Will Allow Reimbursement Assessments Of Cardiax Dysfunctions Using Tempus ECG-AF Algorithm.
Natera Analyst Ratings
Annual review | The top ten explosive stocks in the US stock market for 2024 have been released! Applovin emerges as the dark horse of the year in AI, MSTR astonishes the market with a fivefold increase for the year, and Tesla makes a comeback in the last
As of the market close on December 11, the S&P 500 Index has risen by 27% year-to-date, surpassing 6,000 points; the Nasdaq Composite Index has accumulated a rise of over 33%, reaching a milestone of 0.02 million points, exceeding market expectations.
Natera Announces Enrollment Of First Patients In SAGITTARIUS A Randomized Phase III Clinical Trial In Colon Cancer; ~700-900 Patients Expected To Be Enrolled Across More Than 20 Sites
Cathie Wood's Ark Invest Trims Tesla Exposure Amid Searing Rally, Sells $21.8M Worth Of Stock — Bets On This AI Medical Company
Editas Cut to Equal Weight by Wells Fargo Over Reni-cel Positioning
Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $11 Price Target